SZULING LANGER: Open Payments
NPI 1821648593 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$155 in 8 payments from 6 companies in 2025. Trend: 2023 $300 · 2024 $160 · 2025 $155
Food & beverage: $155
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $39 |
| TOLMAR, INC. | 2 | $29 |
| Janssen Biotech, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Verity Pharmaceuticals Inc. | 1 | $19 |
Products named: Xtandi, ERLEADA, PADCEV, ORGOVYX, Trelstar, JATENZO, ELIGARD.
Industry payments across TX — which companies pay providers there.
